In this issue:
PRA predicts cardiac death in systolic HF
CRT responses predict probability of full response in advanced HF
Cardiac/noncardiac dysfunction increases HF incidence
CRT improves HF with normal QRS duration
HGF predicts mortality in advanced HF
Remodelling biomarkers give complementary prognostic information in ADHF
Plasma myostatin levels increased in HF
Urinary albumin-creatinine ratio increases common in HF
Aliskiren improves neurohumoral biomarkers regardless of MRA therapy
Nesiritide has little effect on dyspnoea in acute HF
High HbA1c increases risk of HF in type 1 diabetics
Please login below to download this issue (PDF)